A phase I study of intravenous RMP-7 with carboplatin in patients with progression of malignant glioma (Q33504982)

27 July 2017

A phase I study of intravenous RMP-7 with carboplatin in patients with progression of malignant glioma (English)

1 reference

27 July 2017

1 reference

Ford J

1

1 reference

27 July 2017

Osborn C

series ordinal

2

1 reference

27 July 2017

Barton T

series ordinal

3

1 reference

27 July 2017

Bleehen NM

series ordinal

4

1 reference

27 July 2017

1 October 1998

1 reference

European Journal of Cancer

27 July 2017

1 reference

27 July 2017

34

1 reference

27 July 2017

11

1 reference

27 July 2017

1807-1811

1 reference

Evaluation of BCNU and/or radiotherapy in the treatment of anaplastic gliomas. A cooperative clinical trial

27 July 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2898%2900155-5

7 January 2021

A Medical Research Council trial of two radiotherapy doses in the treatment of grades 3 and 4 astrocytoma. The Medical Research Council Brain Tumour Working Party

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2898%2900155-5

7 January 2021

High activity iodine-125 interstitial implant for gliomas

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2898%2900155-5

7 January 2021

Meta-analysis of radiation therapy with and without adjuvant chemotherapy for malignant gliomas in adults.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2898%2900155-5

7 January 2021

An overview of published results from randomized studies of nitrosoureas in primary high grade malignant glioma

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2898%2900155-5

7 January 2021

Good practice in the management of adults with malignant cerebral glioma: clinical guidelines. Working Group, Royal College of Physicians.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2898%2900155-5

7 January 2021

Chemotherapy for anaplastic oligodendroglioma. National Cancer Institute of Canada Clinical Trials Group

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2898%2900155-5

7 January 2021

Assay of anti-cancer drugs in tissue culture: relationship of relapse free interval (RFI) and in vitro chemosensitivity in patients with malignant cerebral glioma

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2898%2900155-5

7 January 2021

Assay of anticancer drugs in tissue culture: Cell cultures of biopsies from human astrocytoma

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2898%2900155-5

7 January 2021

In vitro chemosensitivity of brain tumors to cisplatin and its analogues, iproplatin and carboplatin.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2898%2900155-5

7 January 2021

Intravenous carboplatin for recurrent malignant glioma: a phase II study

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2898%2900155-5

7 January 2021

Pathway across blood-brain barrier opened by the bradykinin agonist, RMP-7.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2898%2900155-5

7 January 2021

Intracarotid infusion of RMP-7, a bradykinin analog: a method for selective drug delivery to brain tumors

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2898%2900155-5

7 January 2021

Permeability of the blood brain barrier by the bradykinin agonist, RMP-7: evidence for a sensitive, auto-regulated, receptor-mediated system

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2898%2900155-5

7 January 2021

Carboplatin dosage: prospective evaluation of a simple formula based on renal function

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2898%2900155-5

7 January 2021

ECG abnormalities in patients with subarachnoid haemorrhage and intracranial tumours

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2898%2900155-5

7 January 2021

Electrocardiographic changes in patients with brain tumors

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2898%2900155-5

7 January 2021

Enhanced tumor uptake of carboplatin and survival in glioma-bearing rats by intracarotid infusion of bradykinin analog, RMP-7.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2898%2900155-5

7 January 2021

Hyperosmotic blood-brain barrier disruption in brains of rats with an intracerebrally transplanted RG-C6 tumor.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2898%2900155-5

7 January 2021

Effects of adrenal cortical steroids and osmotic blood-brain barrier opening on methotrexate delivery to gliomas in the rodent: the factor of the blood-brain barrier

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2898%2900155-5

7 January 2021

Osmotic blood-brain barrier disruption and chemotherapy in the treatment of high grade malignant glioma: patient series and literature review

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2898%2900155-5

7 January 2021

Therapeutic efficacy of multiagent chemotherapy with drug delivery enhancement by blood-brain barrier modification in glioblastoma.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2898%2900155-5

7 January 2021

Intra-arterial mannitol infusion in the chemotherapy for malignant brain tumors

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2898%2900155-5

7 January 2021

10.1016/S0959-8049(98)00155-5

Identifiers

DOI

1 reference

27 July 2017

1 reference